CarlJDeSelmMDPhD

Radiation Oncology • Saint Louis, MO

Assistant Professor

Join to view full profile

Dr. DeSelm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. DeSelm's full profile

Already have an account?

Office
4921 Parkview Pl
Dept Oncology
Saint Louis, MO 63110
Phone+1 314-747-7236

Fax+1 314-362-8099

Summary

Carl DeSelm Lab

Developing cellular immunotherapies for difficult cancers.

Education & Training

Memorial Sloan Kettering Cancer CenterTranslational Research, 2017 - 2018
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2012 - 2013
Washington University in St. Louis School of MedicineClass of 2012

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2018 - 2025
NY State Medical License 2013 - 2019
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Agilent 2020 Early Career Professor Award Agilent, 2020
Early Independence Award (DP5) NIH

Publications & Presentations

PubMed

2 citations
Chimeric antigen receptor macrophages target and resorb amyloid plaques.
Alexander B Kim, Qingli Xiao, Ping Yan, Qiuyun Pan, Gaurav Pandey
JCI Insight. 2024-02-06
9 citations
Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach.
Dhivya Sridaran, Elliot Bradshaw, Carl DeSelm, Russell Pachynski, Kiran Mahajan
Cell Reports. Medicine. 2023-10-17
3 citations
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.
Miriam T Jacobs, Pamela Wong, Alice Y Zhou, Michelle Becker-Hapak, Nancy D Marin
Clinical Cancer Research. 2023-10-13

Abstracts/Posters

MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Telluride Alum Receives Prestigious HonorOctober 23rd, 2020

Grant Support

The Role Of Paxillin In The OsteoclastNational Institute On Aging2009–2011